BRAF and neoplasm: In melanoma, loss of PTEN is associated with decreased infiltration and function of tumor-infiltrating T cells, possibly due to overexpression of immunosuppressive cytokines31, and shorter time to brain metastasis in patients with BRAF-mutant high-risk stage III melanoma39.